207 related articles for article (PubMed ID: 23876399)
1. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: a meta-analysis.
Cho YA; Kim J
Cytokine; 2013 Oct; 64(1):213-20. PubMed ID: 23876399
[TBL] [Abstract][Full Text] [Related]
2. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson's disease.
Wang Y; Zhou M; Wang Y; Jiang D; Deng X
J Neural Transm (Vienna); 2019 Nov; 126(11):1465-1470. PubMed ID: 31471711
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of MCP-1 and CCR2 genes and IgA nephropathy risk.
Gao J; Liu X; Wei L; Niu D; Wei J; Wang L; Ge H; Wang M; Yu Q; Jin T; Tian T; Dai Z; Fu R
Oncotarget; 2016 Nov; 7(47):77950-77957. PubMed ID: 27788494
[TBL] [Abstract][Full Text] [Related]
4. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Liu GX; Zhang X; Li S; Koiiche RD; Sindsceii JH; Song H
Tumour Biol; 2013 Oct; 34(5):2741-6. PubMed ID: 23657965
[TBL] [Abstract][Full Text] [Related]
6. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
[TBL] [Abstract][Full Text] [Related]
7. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women.
Attar R; Agachan B; Kuran SB; Cacina C; Sozen S; Yurdum LM; Attar E; Isbir T
In Vivo; 2010; 24(2):243-8. PubMed ID: 20364004
[TBL] [Abstract][Full Text] [Related]
8. CCR2-64I is a risk factor for development of bladder cancer.
Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
[TBL] [Abstract][Full Text] [Related]
9. Combined association of CCR2-V64I and MCP-1-2518A/G polymorphisms with generalised aggressive periodontitis in Chinese.
Zhu XL; Meng HX; Xu L; Zhang L; Chen ZB; Shi D; Feng XH
Chin J Dent Res; 2010; 13(2):109-14. PubMed ID: 21264360
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: a meta-analysis.
Wang Y; Zhang W; Li S; Song W; Chen J; Hui R
Atherosclerosis; 2011 Nov; 219(1):224-30. PubMed ID: 21868018
[TBL] [Abstract][Full Text] [Related]
11. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease.
Bai J; Song H; Cai C; Zhang M; Xu S; Tan J
DNA Cell Biol; 2012 Jun; 31(6):1058-63. PubMed ID: 22276574
[TBL] [Abstract][Full Text] [Related]
12. MCP-1 and CCR2 gene variants and the risk for osteoporosis and osteopenia.
Eraltan H; Cacina C; Kahraman OT; Kurt O; Aydogan HY; Uyar M; Can A; Cakmakoğlu B
Genet Test Mol Biomarkers; 2012 Apr; 16(4):229-33. PubMed ID: 22081934
[TBL] [Abstract][Full Text] [Related]
13. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.
Bektas-Kayhan K; Unur M; Boy-Metin Z; Cakmakoglu B
Oral Dis; 2012 Jan; 18(1):55-9. PubMed ID: 21883707
[TBL] [Abstract][Full Text] [Related]
14. Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.
Kang SW; Park SJ; Kim YW; Kim YH; Sohn HS; Yoon YC; Joo H; Jeong KH; Lee SH; Lee TW; Ihm CG
Int J Immunogenet; 2008 Feb; 35(1):25-31. PubMed ID: 18186797
[TBL] [Abstract][Full Text] [Related]
15. Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population.
Bjarnadottir K; Eiriksdottir G; Aspelund T; Gudnason V
Atherosclerosis; 2006 Oct; 188(2):341-6. PubMed ID: 16356504
[TBL] [Abstract][Full Text] [Related]
16. The impact of MCP1-2518A/G and CCR2-V64I genetic polymorphisms in Egyptian sickle cell disease patients.
Ibrahim NS; Makhlouf MM; Shahin GH; Elghamrawy MK; Hussein NM
Exp Mol Pathol; 2022 Oct; 128():104834. PubMed ID: 36155203
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.
Yeh CB; Tsai HT; Chen YC; Kuo WH; Chen TY; Hsieh YH; Chou MC; Yang SF
J Surg Oncol; 2010 Sep; 102(3):264-70. PubMed ID: 20740585
[TBL] [Abstract][Full Text] [Related]
18. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis.
Wang B; Zhu JM; Fan YG; Feng CC; Chen GM; Chen H; Pan HF; Ye DQ
Gene; 2013 Sep; 527(1):95-101. PubMed ID: 23747396
[TBL] [Abstract][Full Text] [Related]
19. Relationship between CCR2-V64I polymorphism and cancer risk: a meta-analysis.
Huang Y; Chen H; Wang J; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Jul; 524(1):54-8. PubMed ID: 23612252
[TBL] [Abstract][Full Text] [Related]
20. Frequency of MCP-1 (rs1024611) and CCR2 (rs1799864) gene polymorphisms and its effect on gene expression level in patients with AgP.
Gunpinar S; Alptekin NO; Ucar VB; Acar H
Arch Oral Biol; 2017 Aug; 80():209-216. PubMed ID: 28458180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
